Ani Pharmaceuticals Inc (ANIP)
SG&A Expense Growth
24.45%
Quarterly · Period ending:
ANIP SG&A Expense Growth
Latest reported24.45%period ending
Latest reported24.45%period ending
ANIP Quarterly SG&A Growth (QoQ) (0.00% → 24.45%)
Latest values, visible window
High-resolution chart · PNG
ANIP sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 7.0774% | |
| -28.8801% | |
| 57.1065% | |
| 35.4527% | |
| 2.0271% | |
| 0% | |
| 0% |